The co-founders of the hemp drink Kaló are battling in court over the future of the brand tied to a New Jersey cannabis company.
in September 2019 and Terra Tech purchased all of the stock in the company owned by the VandeVrede family, officials said.
Voorhees offered VandeVrede 60% interest in the hemp beverage venture while he kept the remaining 40%, according to a copy of the operating agreement. Later, 15% of the Voorhees’ interest was transferred to Makalo, a marketing company engaged by the business. However, despite Voorhees serving as the product developer and flavor specialist behind the scenes at Kaló, VandeVrede and his family took full credit for the product and coined themselves the “Family Behind the Flavor,” the lawsuit alleges.
The Voorhees’ lawsuit argues the funding was instead used to cover Hillview Med’s increased expenses as it was developing its cannabis cultivation facility.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
‘Succession’ Finale: Nicholas Braun on That Greg-Tom Fight SceneNicholas Braun on that TomGreg fight scene in the 'Succession' finale.
Les mer »
Multichain Halts Some Services as CEO is AWOL | CoinMarketCapCryptoNews: Cross-chain protocol Multichain has halted services for several chains due to the inability to contact its CEO, Zhaojun, leading to speculation that the leadership may have been arrested in China. 👀
Les mer »
Nvidia CEO feels 'perfectly safe' sourcing from Taiwan's TSMC amid China tensionsNvidia's founder and CEO Jensen Huang exudes confidence that the trillion-dollar-chipmaker has what it takes to navigate geopolitically sensitivities.
Les mer »
Removed Max Series Fans Fight For Season 3 Using Netflix Cancellation Billboard TrendFans of the removed Max series Raised by Wolves follow in the footsteps of the campaign to save Warrior Nun with a billboard of their own.
Les mer »
Kentucky’s Risky $42 Million Bet to Fight the Opioid Crisis With PsychedelicsA Kentucky advisory commission has allocated millions to study the controversial, plant-based hallucinogen ibogaine, but is it the answer to combating the state's opioid crisis?
Les mer »